Amgen
-
Press Releases
AWS Joins Forces With Amgen on Generative AI Solutions to Accelerate Advanced Therapies
At AWS re:Invent, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), today announced that Amgen is expanding its work with AWS to create generative artificial intelligence (generative AI)-based solutions to help discover, develop, and increase the manufacturing throughput of medicines for patients suffering from serious illnesses. Amgen will also use AWS’s reliable global infrastructure and advanced services…
Read More » -
Press Releases
Amgen Goes for AWS
SEATTLE–(BUSINESS WIRE)–Nov. 27, 2018– Today, Amazon Web Services, Inc. (AWS), an Amazon.com company (NASDAQ: AMZN), announced that Amgen, one of the world’s leading biotechnology companies, is moving the vast majority of its cloud infrastructure to AWS to accelerate innovation, drive cost efficiencies, and unlock new insights from data to help deliver new treatments to patients with serious illnesses. As the company moves more of its technology infrastructure…
Read More »